DECREASED SENSITIVITY OF AN INTERFERON-RESISTANT SUBLINE OF MURINE LEUKEMIA L-1210 CELLS TO TOXIC EFFECTS OF RICIN AND ABRIN

被引:2
作者
BESANCON, F [1 ]
ANKEL, H [1 ]
机构
[1] MED COLL WISCONSIN,DEPT BIOCHEM,MILWAUKEE,WI 53226
基金
美国国家科学基金会;
关键词
D O I
10.1016/0006-291X(79)91481-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Approximately two to four times higher concentrations of the plant toxins abrin and ricin are required to inhibit protein synthesis in interferon-resistant L-1210R cells to the same degree as in interferon-sensitive L-1210S cells. However, amounts of interferon 10-fold higher than those required for protection from viral infection fail to show any effect on ricin intoxication of L-1210S cells. © 1979.
引用
收藏
页码:818 / 825
页数:8
相关论文
共 17 条
  • [1] BENNETT V, 1977, RECEPTORS RECOGNIT B, V1, P3
  • [2] INHIBITION OF INTERFERON ACTION BY PLANT LECTINS
    BESANCON, F
    ANKEL, H
    [J]. NATURE, 1974, 250 (5469) : 784 - 786
  • [3] BINDING OF INTERFERON TO GANGLIOSIDES
    BESANCON, F
    ANKEL, H
    [J]. NATURE, 1974, 252 (5483) : 478 - 480
  • [4] SPECIFICITY AND REVERSIBILITY OF INTERFERON GANGLIOSIDE INTERACTION
    BESANCON, F
    ANKEL, H
    BASU, S
    [J]. NATURE, 1976, 259 (5544) : 576 - 578
  • [5] BESANCON F, 1977, TEX REP BIOL MED, V35, P282
  • [6] BIZZINI B, 1977, RECEPTORS RECOGNITIO, V1, P175
  • [7] INTERACTIONS OF PLANT LECTINS WITH GLYCOLIPIDS IN LIPOSOMES
    BOLDT, DH
    SPECKART, SF
    RICHARDS, RL
    ALVING, CR
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1977, 74 (01) : 208 - 214
  • [8] COLLIER RJ, 1977, RECEPTORS RECOGNIT B, V1, P69
  • [9] PURIFICATION OF MOUSE INTERFERON BY SEQUENTIAL AFFINITY CHROMATOGRAPHY ON POLY(U)-AGAROSE AND ANTIBODY-AGAROSE COLUMNS
    DEMAEYERGUIGNARD, J
    TOVEY, MG
    GRESSER, I
    DEMAEYER, E
    [J]. NATURE, 1978, 271 (5646) : 622 - 625
  • [10] INTERFERON AND CELL-DIVISION .9. INTERFERON-RESISTANT L1210 CELLS - CHARACTERISTICS AND ORIGIN
    GRESSER, I
    BANDU, MT
    BROUTYBO.D
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 52 (02) : 553 - 559